Azithromycin API Regulatory Requirements — FDA, EMA, ANVISA, and Global Markets

Importing and using Azithromycin API for pharmaceutical manufacturing requires compliance with the regulatory framework of the destination market. This guide covers key requirements for the major regulated markets where Indian Azithromycin API is supplied.

USA — US FDA Requirements

• Azithromycin API must be manufactured at a site with an active US FDA Drug Master File (DMF) or FDA inspection history
• USP grade specification required
• Annual Product Reviews (APR) and change notification requirements apply
• Manufacturer must be listed in your ANDA or NDA

European Union — EMA Requirements

• EP grade specification required
• Certificate of Suitability (CEP) from EDQM is the preferred route
• Alternatively, full API data package in CTD format (Module 3.2.S)
• GMP certificate from an EU-recognised authority or WHO-GMP accepted

Brazil — ANVISA Requirements

• WHO-GMP certification of the API manufacturer required
• USP or BP grade accepted
• Full CoA with HPLC, related substances, and residual solvents data
• ANVISA may require GMP inspection or recognition of foreign GMP certificate

Other Key Markets

• Mexico (COFEPRIS) — WHO-GMP + USP/BP grade + CoA + certificate of origin
• Australia (TGA) — WHO-GMP or TGA-approved manufacturer; BP/USP grade
• South Korea (MFDS) — WHO-GMP; KP or USP/BP/EP grade accepted
• South Africa (SAHPRA) — WHO-GMP; Ph.Int. or USP/BP/EP grade
• Philippines (FDA) — WHO-GMP; USP/BP grade; LTO (License to Operate) required for importer

Aarise Pharmaceuticals is WHO-GMP certified and has experience exporting Azithromycin API to regulated markets across Americas, Europe, Asia-Pacific, and Africa. Our export team can advise on specific documentation requirements for your market.

Contact our regulatory export team →